Ion channels and amino acid transporters support the growth and invasion of primary brain tumors

Molecular Neurobiology

Volumn 29, Issue 1, 2004, Pages 61-71

  Sontheimer, Harald ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Cell migration; Cell volume; Chloride; Excitotoxicity; Glioma; Glutamate; Invasion; Ion channel; Metastasis

Indexed keywords

AMINO ACID TRANSPORTER; CHLORIDE CHANNEL; EXCITOTOXIN; GLUTAMIC ACID; ION CHANNEL;

AMINO ACID TRANSPORT; BRAIN CANCER; BRAIN TUMOR; CELL MIGRATION; CELL VOLUME; EXTRACELLULAR SPACE; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HOMEOSTASIS; HUMAN; INVASIVE CARCINOMA; METASTASIS; NERVE CELL NECROSIS; NONHUMAN; REVIEW; SEIZURE; TUMOR CELL; TUMOR GROWTH; ANIMAL; CANCER INVASION; CELL DIVISION; METABOLISM; PATHOLOGY;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; BRAIN NEOPLASMS; CELL DIVISION; GLIOMA; GLUTAMIC ACID; HUMANS; ION CHANNELS; NEOPLASM INVASIVENESS;

EID: 2542479034     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:29:1:61     Document Type: Review

References (48)

1. Reier P. J. (1986) Gliosis following CNS injury: The anatomy of astrocytic scars and their influences on axonal elongation, in Astrocytes, Cell Biology and Pathology of Astrocytes, eds., Fedoroff, S. and Vernadakis A., Academic Press, Orlando, pp. 263-324.
2. Ridet J. L., Malhotra S. K., Privat A., and Gage F. H. (1997) Reactive astrocytes: cellular and molecular cues to biological function. TINS 20, 570-577.
3. Unger J. W. (1998) Glial reaction in aging and Alzheimer's disease. Microsc. Res. Tech. 43, 24-28.
4. Collins V. P. (2002) Cellular mechanisms targeted during astrocytoma progression. Cancer Lett. 188, 1-7.
5. Von Deimling A., Louis D. N., and Wiestler O. D. (1995) Molecular pathways in the formation of gliomas. Glia 15, 328-338.
6. Tang P., Steck P. A., and Yung W. K. A. (1997) The autocrine loop of TGF-α/EGFR and brain tumors. J. Neurooncol. 35, 303-314.
7. Maher E. A., Furnari F. B., Bachoo R. M., Rowitch D. H., Louis D. N., Cavenee W. K., and DePinho R. A. (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15, 1311-1333.
8. Holland E. C., Hively W. P., DePinho R. A., and Varmus H. E. (1998) A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12, 3675-3685.
9. Forsyth P. A., Wong H., Laing T. D., et al. (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br. J. Cancer 79, 1828-1835.
10. Gary S. C., Kelly G. M., and Hockfield S. (1998) BEHAB/brevican: A brain-specific lectican implicated in gliomas and glial cell motility. Curr. Opin. Neurobiol. 8, 576-581.
11. Thorsen F. and Tysnes B. B. (1997) Brain tumor cell invasion, anatomical and biological considerations. Anticancer Research 17, 4121-4126.
12. Laerum O. D., Bjerkvig R., Steinsvag S. K., and de Ridder L. (1984) Invasiveness of primary brain tumors. Cancer Metastasis Reviews 3, 223-236.
13. Giese A., Rief M. D., Loo M. A., and Berens M. E. (1994) Determinants of human astrocytoma migration. Cancer Res. 54, 3897-3904.
14. Manning T. J., Jr., Parker J. C., and Sontheimer H. (2000) Role of lysophosphatidic acid and rho in glioma cell motility. Cell Motil Cytoskeleton 45, 185-199.
15. Vargova L., Homola A., Zamecnik J., Tichy M., Benes V., and Sykova E. (2003) Diffusion parameters of the extracellular space in human gliomas. Glia 42, 77-88.
16. + ion channel blockers. J. Neurosci. 19, 5942-5954.
17. Takano T., Lin J. H., Arcuino G., Gao Q., Yang J., and Nedergaard M. (2001) Glutamate release promotes growth of malignant gliomas. Nat. Med. 7, 1010-1015.
18. Ye Z. C. and Sontheimer H. (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 59, 4383-4391.
19. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
20. Rothstein J. D. (1996) Excitotoxicity hypothesis. Neurology 47, S19-25.
21. Ransom C. B., O'Neal J. T., and Sontheimer H. (2001) Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J. Neurosci. 21, 7674-7683.
22. Jentsch T. J., Friedrich T., Schriever A., and Yamada H. (1999) The CLC chloride channel family. Pflügers Arch. 437, 783-795.
23. Jentsch T. J., Stein V., Weinreich F., and Zdebik A. A. (2002) Molecular structure and physiological function of chloride channels. Physiol. Rev. 82, 503-568.
24. Olsen M. L., Schade S., Lyons S. A., Amarillo M. D., and Sontheimer H. (2003) Expresssion of voltage-gated chloride channels in human glioma cells. J. Neurosci. 2, 5572-5582.
25. Greger R. (1990) Chloride channel blockers. Methods in Enzymology 191, 793-810.
26. DeBin J. A., Maggio J. E., and Strichartz G. R. (1993) Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am. J. Physiol. 264, C361-369.
27. Ullrich N. and Sontheimer H. (1996) Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am. J. Physiol. 270, C1511-C1521.
28. Lyons S. A., O'Neal J, and Sontheimer H. (2002) Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 39, 162-173.
29. (2002) TransMolecular receives FDA approval for 131-I-TM-601 IND application. Expert Rev. Anticancer Ther. 2, p. 139.
30. - channel in type R2 reactive astrocytes from adult rat brain. Glia 42, 325-339.
31. Ullrich N., Bordey A., Gillespie G. Y., and Sontheimer H. (1998) Expression of voltage-activated chloride currents in acute slices of human gliomas. Neurosci. 83, 1161-1173.
32. Deshane J., Garner C. C., and Sontheimer H. (2003) Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J. Biol. Chem. 278, 4135-4144.
33. Duszyk M., Shu Y., Sawicki G., Radomski A., Man S. F., and Radomski M. W. (1999) Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells. Can. J. Physiol. Pharmacol. 77, 529-535.
34. Amberger V. R., Avellana-Adalid V., Hensel T., Baron-Van Evercooren A., and Schwab M. E. (1997) Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin. Europ. J. Neurosci. 9, 151-162.
35. Levison S. W., Chuang C., Abramson B. J., and Goldman J. E. (1993) The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated. Dev. 119, 611-622.
36. Simpson P. B. and Armstrong R. C. (1999) Intracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration. Glia 26, 22-35.
37. Noble M. and Mayer-Pröschel M. (1997) Growth factors, glia and gliomas. J. Neurooncol. 35, 193-209.
38. Andersen P., Dingledine R., Gjerstad L., Langmoen I. A., and Laursen A. M. (1980) Two different responses of hippocampal pyramidal cells to application of gamma-amino butyric acid. J. Physiol. 305, 279-296.
39. LoTurco J. J., Owens D. F., Heath M. J. S., Davis M. B. E., and Kriegstein A. R. (1995) GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 15, 1287-1298.
40. Hammoud M. A., Sawaya R., Shi W., Thall P. F., and Leeds N. E. (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J. Neurooncol. 27, 65-73.
41. Danbolt N. C. (2001) Glutamate uptake. Prog. Neurobiol. 65, 1-105.
42. Ye Z. C., Rothstein J. D., and Sontheimer H. (1999) Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J. Neurosci. 19, 10,767-10,777.
43. Rossi D. J., Oshima T., and Attwell D. (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316-321.
44. Sato H., Tamba M., Ishii T., and Bannai S. (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11,455-11,458.
45. Tang P., Steck P. A., and Yung W. K. (1997) The autocrine loop of TGF-alpha/EGFR and brain tumors. J. Neurooncol. 35, 303-314.
46. Iida M., Sunaga S., Hirota N., Kuribayashi N., Sakagami H., Takeda M., and Matsumoto K. (1997) Effect of glutathione-modulating compounds on hydrogen-peroxide-induced cytotoxicity in human glioblastoma and glioma cell lines. J. Cancer Res. Clin. Oncol. 123, 619-622.
47. Gochenauer G. E. and Robinson M. B. (2001) Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(-) subunits. J. Neurochem. 78, 276-286.
48. Oberndorfer S., Schmal T., Lahrmann H., Urbanits S., Lindner K., and Grisold W. (2002) The frequency of seizures in patients with primary brain tumors or cerebral metastases. Wien Klin. Wochenschr. 114, 911-916.